Handelsbanken Fonder Ab Tg Therapeutics, Inc. Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 49,900 shares of TGTX stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,900
Previous 40,700
22.6%
Holding current value
$1.67 Million
Previous $724,000
61.19%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TGTX
# of Institutions
345Shares Held
87.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$515 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$381 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$304 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$120 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$107 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.86B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...